Search results

Australia’s Nuclear Science and Technology Organisation (ANSTO) is well-known for facilitating incredible science and creating life-saving nuclear medicines, but for the last 40 years it’s been quietly producing a largely unsung net zero hero: Neutron Transmutation Doped (NTD) silicon.

ANSTO provides secondary students with a range of learning resources for those interested in science or studying for exams. For teachers, ANSTO provides learning resources and professional development, as well as in-school-term science tours and videoconferences. Workbooks are provided as required learning material to accompany a school visit to ANSTO. They can also be used on their own as a classroom resource.

This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors and platform users and collaborators safe and minimise the risk of the spread of COVID-19 infection.

The Australian Government recently signed a landmark emissions reduction technology deal with Great Britain, which includes nuclear energy and clean hydrogen among the six key low emission technologies the two countries hope to advance.

Stage 1 of the Stawell Underground Physics Laboratory was officially opened today. It will be home to multi-disciplinary scientists from five research partners who help us understand dark matter.

Challenge your understanding of nuclear science and technology with fun secondary school activities, exciting competitions and unique tours of our facilities.

ANSTO can analyse minute amounts of organic or inorganic matter embedded in a complex material

Virtual activities celebrating the benefits of nuclear science and technology held for National Science Week

A new study by researchers from Curtin University using the infrared (IR) and X-ray fluorescence microscopy (XFM) beamlines at the Australian Synchrotron has provided a better understanding of the chemical and elemental composition of latent fingermarks.

ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.

Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape

Meeting of minds about potential next-generation cancer treatment for Australians